| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 1.33e-05 | 262 | 83 | 8 | GO:0140097 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.49e-05 | 127 | 83 | 6 | GO:0008094 | |
| GeneOntologyBiologicalProcess | mitotic G1 phase | 1.52e-05 | 2 | 81 | 2 | GO:0000080 | |
| GeneOntologyBiologicalProcess | G1 phase | 1.52e-05 | 2 | 81 | 2 | GO:0051318 | |
| GeneOntologyBiologicalProcess | sex differentiation | 7.23e-05 | 352 | 81 | 8 | GO:0007548 | |
| GeneOntologyBiologicalProcess | chromosome organization | RIF1 SYCP2 ATRX ZGRF1 WRN NAV2 SMARCC2 MSH4 TEP1 AXIN2 CEP63 | 7.42e-05 | 686 | 81 | 11 | GO:0051276 |
| GeneOntologyBiologicalProcess | mitotic interphase | 9.09e-05 | 4 | 81 | 2 | GO:0051329 | |
| GeneOntologyBiologicalProcess | reproductive structure development | 1.30e-04 | 383 | 81 | 8 | GO:0048608 | |
| GeneOntologyBiologicalProcess | reproductive system development | 1.42e-04 | 388 | 81 | 8 | GO:0061458 | |
| GeneOntologyBiologicalProcess | gonad development | 1.51e-04 | 292 | 81 | 7 | GO:0008406 | |
| GeneOntologyBiologicalProcess | interphase | 1.51e-04 | 5 | 81 | 2 | GO:0051325 | |
| GeneOntologyBiologicalProcess | development of primary sexual characteristics | 1.67e-04 | 297 | 81 | 7 | GO:0045137 | |
| GeneOntologyBiologicalProcess | chromosome organization involved in meiotic cell cycle | 2.17e-04 | 75 | 81 | 4 | GO:0070192 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle phase | 2.26e-04 | 6 | 81 | 2 | GO:0098763 | |
| GeneOntologyBiologicalProcess | nucleosome organization | 2.43e-04 | 142 | 81 | 5 | GO:0034728 | |
| GeneOntologyCellularComponent | condensed chromosome | 2.20e-04 | 307 | 83 | 7 | GO:0000793 | |
| GeneOntologyCellularComponent | chromosomal region | 2.67e-04 | 421 | 83 | 8 | GO:0098687 | |
| GeneOntologyCellularComponent | eukaryotic translation initiation factor 3 complex, eIF3m | 5.51e-04 | 9 | 83 | 2 | GO:0071541 | |
| GeneOntologyCellularComponent | synaptonemal complex | 8.10e-04 | 46 | 83 | 3 | GO:0000795 | |
| GeneOntologyCellularComponent | synaptonemal structure | 8.10e-04 | 46 | 83 | 3 | GO:0099086 | |
| Domain | ARM-type_fold | 1.59e-05 | 339 | 81 | 9 | IPR016024 | |
| Domain | GABAAa_rho_rcpt | 1.86e-05 | 2 | 81 | 2 | IPR008057 | |
| Domain | EIF3C_N_dom | 1.86e-05 | 2 | 81 | 2 | IPR008905 | |
| Domain | eIF-3c_N | 1.86e-05 | 2 | 81 | 2 | PF05470 | |
| Domain | EIF3C | 1.86e-05 | 2 | 81 | 2 | IPR027516 | |
| Domain | SYCP1/2 | 5.56e-05 | 3 | 81 | 2 | IPR024835 | |
| Domain | IQSEC_PH | 5.56e-05 | 3 | 81 | 2 | IPR033742 | |
| Domain | IQ_SEC7_PH | 5.56e-05 | 3 | 81 | 2 | PF16453 | |
| Domain | P-loop_NTPase | MYH9 ATRX N4BP2 ZGRF1 WRN NAV3 NAV2 NAV1 MSH4 TEP1 REM2 RAB33B | 2.80e-04 | 848 | 81 | 12 | IPR027417 |
| Domain | - | 3.64e-04 | 746 | 81 | 11 | 3.40.50.300 | |
| Domain | LINK | 1.40e-03 | 13 | 81 | 2 | SM00445 | |
| Domain | Link_dom | 1.40e-03 | 13 | 81 | 2 | IPR000538 | |
| Domain | Xlink | 1.40e-03 | 13 | 81 | 2 | PF00193 | |
| Domain | LINK_1 | 1.40e-03 | 13 | 81 | 2 | PS01241 | |
| Domain | LINK_2 | 1.40e-03 | 13 | 81 | 2 | PS50963 | |
| Domain | - | 1.88e-03 | 15 | 81 | 2 | 1.10.1000.11 | |
| Domain | Sec7 | 1.88e-03 | 15 | 81 | 2 | PF01369 | |
| Domain | Sec7_alpha_orthog | 1.88e-03 | 15 | 81 | 2 | IPR023394 | |
| Domain | Sec7 | 2.14e-03 | 16 | 81 | 2 | SM00222 | |
| Domain | SEC7 | 2.14e-03 | 16 | 81 | 2 | PS50190 | |
| Domain | Sec7_dom | 2.14e-03 | 16 | 81 | 2 | IPR000904 | |
| Domain | PINT | 2.14e-03 | 16 | 81 | 2 | SM00088 | |
| Domain | PCI_dom | 2.42e-03 | 17 | 81 | 2 | IPR000717 | |
| Domain | PCI | 2.42e-03 | 17 | 81 | 2 | PF01399 | |
| Domain | - | 2.58e-03 | 218 | 81 | 5 | 1.10.10.10 | |
| Domain | - | 2.79e-03 | 222 | 81 | 5 | 1.25.10.10 | |
| Domain | IQ | 3.63e-03 | 71 | 81 | 3 | PF00612 | |
| Domain | WHTH_DNA-bd_dom | 4.04e-03 | 242 | 81 | 5 | IPR011991 | |
| Domain | GABAA/Glycine_rcpt | 4.43e-03 | 23 | 81 | 2 | IPR006028 | |
| Domain | SANT_dom | 5.64e-03 | 26 | 81 | 2 | IPR017884 | |
| Domain | ARM-like | 6.38e-03 | 270 | 81 | 5 | IPR011989 | |
| Domain | SANT | 6.53e-03 | 28 | 81 | 2 | PS51293 | |
| Domain | IQ_motif_EF-hand-BS | 7.04e-03 | 90 | 81 | 3 | IPR000048 | |
| Domain | IQ | 7.71e-03 | 93 | 81 | 3 | PS50096 | |
| Pubmed | PHC3 TSHZ3 MYH9 MRTFB N4BP2 ZGRF1 UBR4 NAV1 ANKRD28 ZFHX3 SOX8 OBI1 MED12 | 2.24e-11 | 418 | 83 | 13 | 34709266 | |
| Pubmed | DOCK1 RIF1 MYH9 HIVEP2 N4BP2 RANBP9 NAV3 NAV2 NAV1 KPNA6 CPLANE1 TNS1 OBI1 | 1.44e-10 | 486 | 83 | 13 | 20936779 | |
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 12079279 | ||
| Pubmed | Sensory deficits in mice hypomorphic for a mammalian homologue of unc-53. | 1.31e-08 | 3 | 83 | 3 | 15158073 | |
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 12062803 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | PPP1R2 ELOA PHC3 RIF1 ATRX EIF2B5 IQSEC1 SMARCC2 EIF3C ADARB1 VIRMA MIER1 EIF3CL | 3.75e-08 | 774 | 83 | 13 | 15302935 |
| Pubmed | IQSEC3 MYH9 FXR1 N4BP2 UBR4 RANBP9 IQSEC1 NAV1 SMARCC2 ANKRD28 TNS1 VIRMA SLC12A5 MPRIP | 6.37e-08 | 963 | 83 | 14 | 28671696 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | MRTFB ATRX DTNA N4BP2 ZGRF1 FBXO42 NAV1 KPNA6 POTEJ OBI1 MPRIP | 1.58e-07 | 588 | 83 | 11 | 38580884 |
| Pubmed | Dynamic microtubules catalyze formation of navigator-TRIO complexes to regulate neurite extension. | 4.56e-07 | 7 | 83 | 3 | 25065758 | |
| Pubmed | PPP1R2 PPP1R2B IQSEC3 MYH9 DTNA UBR4 RANBP9 NAV3 IQSEC1 NAV1 SMARCC2 ANKRD28 EIF3C EIF3CL | 4.86e-07 | 1139 | 83 | 14 | 36417873 | |
| Pubmed | Identification of the human testis protein phosphatase 1 interactome. | 6.35e-07 | 68 | 83 | 5 | 21382349 | |
| Pubmed | 1.44e-06 | 335 | 83 | 8 | 15741177 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 1.64e-06 | 341 | 83 | 8 | 32971831 | |
| Pubmed | 1.88e-06 | 153 | 83 | 6 | 10718198 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 1.92e-06 | 608 | 83 | 10 | 36089195 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ELOA PPP1R2B PHC3 RIF1 MYH9 MRTFB ATRX CIAPIN1 RSF1 ANKRD28 EIF3C MPRIP | 2.21e-06 | 934 | 83 | 12 | 33916271 |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 4.04e-06 | 271 | 83 | 7 | 32433965 | |
| Pubmed | ELOA PHC3 RIF1 MYH9 FXR1 TMEM237 AGL MRM1 WRN IQSEC1 SMARCC2 POTEJ VIRMA MPRIP | 4.25e-06 | 1371 | 83 | 14 | 36244648 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 5.37e-06 | 283 | 83 | 7 | 30585729 | |
| Pubmed | Dystrobrevin alpha gene is a direct target of the vitamin D receptor in muscle. | 5.63e-06 | 2 | 83 | 2 | 31940280 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 9153229 | ||
| Pubmed | Identification and characterization of two distinct PPP1R2 isoforms in human spermatozoa. | 5.63e-06 | 2 | 83 | 2 | 23506001 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 12019334 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 22886754 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 19118547 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 28660714 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 19536785 | ||
| Pubmed | EIF3C Promotes Lung Cancer Tumorigenesis by Regulating the APP/HSPA1A/LMNB1 Axis. | 5.63e-06 | 2 | 83 | 2 | 36157221 | |
| Pubmed | High-Confidence Interactome for RNF41 Built on Multiple Orthogonal Assays. | 6.39e-06 | 50 | 83 | 4 | 29560723 | |
| Pubmed | ELOA MYH9 FXR1 ATRX DTNA N4BP2 UBR4 RSF1 NAV2 SMARCC2 CEP295 ZNF84 POTEJ OBI1 | 7.56e-06 | 1442 | 83 | 14 | 35575683 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 7.79e-06 | 560 | 83 | 9 | 21653829 | |
| Pubmed | 8.70e-06 | 17 | 83 | 3 | 21704027 | ||
| Pubmed | HIVEP2 ATRX UBR4 RANBP9 NAV3 KPNA6 ZNF84 EIF3C ADARB1 PLXNB3 MPRIP KLHL4 CEP63 | 1.08e-05 | 1285 | 83 | 13 | 35914814 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | PPP1R2 ELOA RIF1 ATRX TMEM237 EIF2B5 WRN RANBP9 NAV1 ANKRD28 E2F4 EIF3CL MPRIP | 1.44e-05 | 1321 | 83 | 13 | 27173435 |
| Pubmed | Transcriptome profiling of mouse brain and lung under Dip2a regulation using RNA-sequencing. | 1.45e-05 | 20 | 83 | 3 | 31291246 | |
| Pubmed | Cloning and characterization of mouse GABA(C) receptor subunits. | 1.69e-05 | 3 | 83 | 2 | 9507960 | |
| Pubmed | Associations between polymorphisms related to calcium metabolism and human height: the Tromsø Study. | 1.69e-05 | 3 | 83 | 2 | 22390397 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 9839716 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 10542332 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 24195737 | ||
| Pubmed | Exome Sequencing of Uterine Leiomyosarcomas Identifies Frequent Mutations in TP53, ATRX, and MED12. | 1.69e-05 | 3 | 83 | 2 | 26891131 | |
| Pubmed | GABAC receptor sensitivity is modulated by interaction with MAP1B. | 1.69e-05 | 3 | 83 | 2 | 11102469 | |
| Pubmed | Structural basis for regulation of protein phosphatase 1 by inhibitor-2. | 1.69e-05 | 3 | 83 | 2 | 17636256 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 20123002 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 35091793 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 1.98e-05 | 231 | 83 | 6 | 16452087 | |
| Pubmed | 2.08e-05 | 233 | 83 | 6 | 37704626 | ||
| Pubmed | 2.13e-05 | 234 | 83 | 6 | 36243803 | ||
| Pubmed | 2.62e-05 | 653 | 83 | 9 | 22586326 | ||
| Pubmed | 2.76e-05 | 503 | 83 | 8 | 16964243 | ||
| Pubmed | ELOA RIF1 MYH9 ATRX UBR4 CIAPIN1 RSF1 SMARCC2 VIRMA MAGEC2 MED12 | 2.91e-05 | 1014 | 83 | 11 | 32416067 | |
| Pubmed | IQSEC3 MYH9 FXR1 VCAN IQSEC1 NAV1 SMARCC2 EIF3C TNS1 VIRMA EIF3CL SLC12A5 MPRIP | 3.32e-05 | 1431 | 83 | 13 | 37142655 | |
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 11520487 | ||
| Pubmed | Cloning and characterization of human phosphatase inhibitor-2 (IPP-2) sequences. | 3.37e-05 | 4 | 83 | 2 | 7949733 | |
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 10504338 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 22785457 | ||
| Pubmed | Gamma-aminobutyric acid (GABA) receptor rho (GABRR) polymorphisms and risk for essential tremor. | 3.37e-05 | 4 | 83 | 2 | 20820800 | |
| Pubmed | Accelerated reproductive aging in females lacking a novel centromere protein SYCP2L. | 3.37e-05 | 4 | 83 | 2 | 26362258 | |
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 3.40e-05 | 153 | 83 | 5 | 26365490 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 3.91e-05 | 861 | 83 | 10 | 36931259 | |
| Pubmed | 5.25e-05 | 551 | 83 | 8 | 34728620 | ||
| Pubmed | PHC3 RIF1 HIP1 MRTFB ATRX MRM1 WRN ZFHX3 EIF3C HEATR5B VIRMA MED12 MPRIP | 5.27e-05 | 1497 | 83 | 13 | 31527615 | |
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 12431995 | ||
| Pubmed | PNUTS forms a trimeric protein complex with GABA(C) receptors and protein phosphatase 1. | 5.60e-05 | 5 | 83 | 2 | 18325784 | |
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 30144392 | ||
| Pubmed | Protein Phosphatase-1 Inhibitor-2 Is a Novel Memory Suppressor. | 5.60e-05 | 5 | 83 | 2 | 26558779 | |
| Pubmed | 6.03e-05 | 282 | 83 | 6 | 23667531 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | PPP1R2 PPP1R2B ATRX DTNA EIF3C CPLANE1 TNS1 AXIN2 EIF3CL MPRIP | 6.20e-05 | 910 | 83 | 10 | 36736316 |
| Pubmed | AMBN FXR1 RSF1 RANBP9 IQSEC1 SMARCC2 ANKRD28 ZFHX3 KPNA6 CEP295 TEP1 | 6.91e-05 | 1116 | 83 | 11 | 31753913 | |
| Pubmed | Genome duplications and other features in 12 Mb of DNA sequence from human chromosome 16p and 16q. | 7.18e-05 | 92 | 83 | 4 | 10493829 | |
| Pubmed | Isolation and characterization of novel presenilin binding protein. | 8.39e-05 | 6 | 83 | 2 | 10854253 | |
| Pubmed | 8.39e-05 | 6 | 83 | 2 | 17118963 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RIF1 MYH9 FXR1 UBR4 EIF2B5 RSF1 RANBP9 IQSEC1 SMARCC2 ANKRD28 MED12 MPRIP | 8.64e-05 | 1353 | 83 | 12 | 29467282 |
| Pubmed | Global phosphoproteome analysis on human HepG2 hepatocytes using reversed-phase diagonal LC. | 8.84e-05 | 36 | 83 | 3 | 16097034 | |
| Pubmed | 1.17e-04 | 7 | 83 | 2 | 29093530 | ||
| Pubmed | 1.17e-04 | 7 | 83 | 2 | 1315307 | ||
| Pubmed | 1.17e-04 | 7 | 83 | 2 | 8940147 | ||
| Pubmed | Inhibitor-2 prevents protein phosphatase 1-induced cardiac hypertrophy and mortality. | 1.17e-04 | 7 | 83 | 2 | 18689497 | |
| Pubmed | 1.33e-04 | 469 | 83 | 7 | 27634302 | ||
| Pubmed | 1.39e-04 | 634 | 83 | 8 | 34591612 | ||
| Pubmed | PHC3 RIF1 TSHZ3 ATRX DTNA UBR4 SMARCC2 ANKRD28 ZFHX3 EIF3C MIER1 MPRIP | 1.44e-04 | 1429 | 83 | 12 | 35140242 | |
| Pubmed | Interactome mapping suggests new mechanistic details underlying Alzheimer's disease. | 1.49e-04 | 111 | 83 | 4 | 21163940 | |
| Pubmed | Primary cilia are WNT-transducing organelles whose biogenesis is controlled by a WNT-PP1 axis. | 1.56e-04 | 8 | 83 | 2 | 36693320 | |
| Pubmed | Mouse thioredoxin gene maps on chromosome 4, whereas its pseudogene maps on chromosome 1. | 1.56e-04 | 8 | 83 | 2 | 8088797 | |
| Pubmed | 1.56e-04 | 8 | 83 | 2 | 16061792 | ||
| Pubmed | The ORC ubiquitin ligase OBI1 promotes DNA replication origin firing. | 1.62e-04 | 44 | 83 | 3 | 31160578 | |
| Pubmed | Loss of ADAMTS19 causes progressive non-syndromic heart valve disease. | 2.00e-04 | 9 | 83 | 2 | 31844321 | |
| Pubmed | 2.00e-04 | 9 | 83 | 2 | 21292980 | ||
| Pubmed | 2.00e-04 | 9 | 83 | 2 | 24003236 | ||
| Pubmed | 2.00e-04 | 9 | 83 | 2 | 15883645 | ||
| Pubmed | 2.00e-04 | 9 | 83 | 2 | 12175859 | ||
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 2.01e-04 | 120 | 83 | 4 | 31413325 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 2.07e-04 | 857 | 83 | 9 | 25609649 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DOCK1 NADSYN1 MRTFB HIVEP2 ATRX DTNA FBXO42 NAV1 ZFHX3 ZNF84 TEP1 ADARB1 | 2.11e-04 | 1489 | 83 | 12 | 28611215 |
| Pubmed | 2.12e-04 | 506 | 83 | 7 | 30890647 | ||
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 2.31e-04 | 361 | 83 | 6 | 30344098 | |
| Pubmed | TRIM65 regulates microRNA activity by ubiquitination of TNRC6. | 2.42e-04 | 364 | 83 | 6 | 24778252 | |
| Pubmed | DOCK1 AMBN LPIN1 PHC3 HIP1 CD300LF TMEM237 VCAN WRN KPNA6 MAGEC2 | 2.50e-04 | 1293 | 83 | 11 | 15342556 | |
| Pubmed | 2.50e-04 | 10 | 83 | 2 | 16286006 | ||
| Pubmed | Conservation and diversity of eukaryotic translation initiation factor eIF3. | 2.50e-04 | 10 | 83 | 2 | 8995409 | |
| Interaction | HDAC1 interactions | TSHZ3 MYH9 MRTFB ATRX ZGRF1 UBR4 WRN RANBP9 NAV1 SMARCC2 ANKRD28 ZFHX3 KPNA6 E2F4 EIF3C SOX8 VIRMA MIER1 OBI1 MED12 | 1.02e-08 | 1108 | 81 | 20 | int:HDAC1 |
| Interaction | KDM1A interactions | PHC3 TSHZ3 MYH9 MRTFB N4BP2 ZGRF1 UBR4 RANBP9 NAV1 SMARCC2 ANKRD28 ZFHX3 E2F4 SOX8 ADARB1 VIRMA OBI1 MED12 | 2.67e-08 | 941 | 81 | 18 | int:KDM1A |
| Interaction | RCOR1 interactions | TSHZ3 MYH9 MRTFB ZGRF1 UBR4 RANBP9 SMARCC2 ZFHX3 SOX8 VIRMA MIER1 OBI1 MED12 | 8.10e-08 | 494 | 81 | 13 | int:RCOR1 |
| Interaction | NUP43 interactions | FSIP2 PHC3 RIF1 MRTFB EIF2B5 RSF1 WRN ANKRD28 ZFHX3 E2F4 VIRMA MED12 | 7.14e-06 | 625 | 81 | 12 | int:NUP43 |
| Interaction | PHF21A interactions | 9.59e-06 | 343 | 81 | 9 | int:PHF21A | |
| Interaction | NCOR2 interactions | 1.10e-05 | 264 | 81 | 8 | int:NCOR2 | |
| Interaction | AP2B1 interactions | 1.87e-05 | 373 | 81 | 9 | int:AP2B1 | |
| Interaction | CSNK2A1 interactions | PPP1R2 GABRR1 GABRR2 MYH9 FXR1 PSEN2 ATRX EIF2B5 RSF1 SMARCC2 E2F4 EIF3C EIF3CL VDR | 2.49e-05 | 956 | 81 | 14 | int:CSNK2A1 |
| Interaction | CREBBP interactions | MYH9 HIVEP2 ATRX N4BP2 EID1 WRN SMARCC2 KPNA6 VIRMA MIER1 VDR | 2.68e-05 | 599 | 81 | 11 | int:CREBBP |
| Interaction | RAB43 interactions | 3.79e-05 | 47 | 81 | 4 | int:RAB43 | |
| Interaction | VTRNA1-2 interactions | 4.77e-05 | 3 | 81 | 2 | int:VTRNA1-2 | |
| Interaction | FMR1 interactions | 5.62e-05 | 536 | 81 | 10 | int:FMR1 | |
| Interaction | H3C1 interactions | ELOA RIF1 MYH9 ATRX UBR4 RSF1 EID1 NAV3 NAV2 SMARCC2 ZFHX3 EIF3C VIRMA | 5.85e-05 | 901 | 81 | 13 | int:H3C1 |
| Interaction | EIF3A interactions | 9.00e-05 | 355 | 81 | 8 | int:EIF3A | |
| Interaction | H2BC8 interactions | 1.02e-04 | 576 | 81 | 10 | int:H2BC8 | |
| Interaction | HIVEP1 interactions | 1.04e-04 | 186 | 81 | 6 | int:HIVEP1 | |
| Interaction | APC2 interactions | 1.05e-04 | 23 | 81 | 3 | int:APC2 | |
| Interaction | CEP192 interactions | 1.24e-04 | 192 | 81 | 6 | int:CEP192 | |
| Interaction | CPLANE1 interactions | 1.35e-04 | 25 | 81 | 3 | int:CPLANE1 | |
| Interaction | HDLBP interactions | RIF1 FXR1 TMEM237 AGL MRM1 FBXO42 WRN SMARCC2 ANKRD28 POTEJ ADARB1 VIRMA | 1.50e-04 | 855 | 81 | 12 | int:HDLBP |
| Interaction | PPP1R12B interactions | 1.62e-04 | 68 | 81 | 4 | int:PPP1R12B | |
| Interaction | H3C3 interactions | 1.65e-04 | 495 | 81 | 9 | int:H3C3 | |
| Interaction | APC interactions | 1.69e-04 | 389 | 81 | 8 | int:APC | |
| Interaction | PPP1CC interactions | PPP1R2 PPP1R2B RIF1 MYH9 RANBP9 NAV1 KPNA6 TNS1 VIRMA MPRIP VDR | 1.73e-04 | 738 | 81 | 11 | int:PPP1CC |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 6.51e-04 | 15 | 46 | 2 | 529 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 1.05e-03 | 19 | 46 | 2 | 563 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.14e-03 | 181 | 46 | 4 | 694 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | DTNA RSF1 WRN NAV3 NAV2 NAV1 ANKRD28 ZFHX3 CEP295 SOX8 TNS1 PLXNB3 VDR PDZRN4 | 7.56e-06 | 1102 | 82 | 14 | M2369 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | DTNA RSF1 WRN NAV3 NAV2 NAV1 ANKRD28 ZFHX3 CEP295 SOX8 TNS1 PLXNB3 VDR PDZRN4 | 9.45e-06 | 1124 | 82 | 14 | MM1070 |
| Coexpression | ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_AD5_NAB_TITERS_GTE_200_VS_LTE_200_1DY_UP | 1.59e-05 | 170 | 82 | 6 | M40872 | |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_GRAN_MONO_PROGENITOR_DN | 1.93e-05 | 176 | 82 | 6 | M8884 | |
| Coexpression | BROWNE_HCMV_INFECTION_48HR_DN | 1.99e-05 | 482 | 82 | 9 | M12144 | |
| Coexpression | GSE39556_CD8A_DC_VS_NK_CELL_DN | 3.74e-05 | 198 | 82 | 6 | M9407 | |
| Coexpression | GSE24726_WT_VS_E2_2_KO_PDC_DAY6_POST_DELETION_DN | 3.96e-05 | 200 | 82 | 6 | M8056 | |
| Coexpression | HALLMARK_MYOGENESIS | 3.96e-05 | 200 | 82 | 6 | M5909 | |
| Coexpression | GERHOLD_ADIPOGENESIS_DN | 4.90e-05 | 64 | 82 | 4 | MM671 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 4.93e-05 | 208 | 82 | 6 | MM581 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | LPIN1 PHC3 RASGRP1 RIF1 MYH9 HIVEP2 ATRX UBR4 RSF1 EID1 RANBP9 ANKRD28 KPNA6 ADARB1 MIER1 | 5.37e-05 | 1492 | 82 | 15 | M40023 |
| Coexpression | KAUFFMANN_DNA_REPAIR_GENES | 8.59e-05 | 230 | 82 | 6 | M11563 | |
| Coexpression | FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_UP | 9.14e-05 | 587 | 82 | 9 | M40869 | |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 1.28e-04 | 155 | 82 | 5 | M39246 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_500 | 1.65e-05 | 382 | 82 | 9 | gudmap_developingGonad_e14.5_ ovary_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 8.14e-05 | 469 | 82 | 9 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000 | SYCP2L PPP1R2B MYH9 HIP1 FXR1 DTNA RSF1 NAV2 NAV1 ANKRD28 E2F4 EIF3C AXIN2 | 1.03e-04 | 991 | 82 | 13 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500 | 1.25e-04 | 387 | 82 | 8 | gudmap_developingGonad_e18.5_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_500 | 1.25e-04 | 387 | 82 | 8 | gudmap_developingGonad_e16.5_ovary_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.39e-04 | 204 | 82 | 6 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | RASGRP1 RIF1 SYCP2 ATRX NAV2 CEP295 MSH4 CHM CPLANE1 ADARB1 KLHL4 | 1.90e-04 | 776 | 82 | 11 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 2.10e-04 | 532 | 82 | 9 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.37e-04 | 225 | 82 | 6 | gudmap_developingGonad_e14.5_ ovary_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | RIF1 ATRX EID1 NAV2 NAV1 ZFHX3 CEP295 CHM CPLANE1 TNS1 KLHL4 | 2.50e-04 | 801 | 82 | 11 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | 2.64e-04 | 806 | 82 | 11 | gudmap_developingGonad_e12.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.88e-04 | 330 | 82 | 7 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.99e-04 | 151 | 82 | 5 | gudmap_developingGonad_P2_ovary_1000_k5 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 1.10e-06 | 180 | 83 | 6 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.51e-06 | 190 | 83 | 6 | da58227565ad6a690828dd8554dd3670222f8582 | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 9.07e-06 | 150 | 83 | 5 | 70ac8ae4b1683fb17278a8e4606f2fa0b94988c0 | |
| ToppCell | COVID-19_Mild-PLT_5|World / Disease Group and Platelet Clusters | 9.67e-06 | 152 | 83 | 5 | 90ba4e8a735ec8921038fa072129535f0e3fd9ae | |
| ToppCell | Control-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.06e-05 | 155 | 83 | 5 | 0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5 | |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.52e-05 | 167 | 83 | 5 | 948504367ecf58144d9dd74d2ec531358fc4b309 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue-Endometrium-7|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.57e-05 | 168 | 83 | 5 | a97e8e07ba949b30805aeed5f60fa5e092b9d3d4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_SLITRK6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.61e-05 | 169 | 83 | 5 | 1c9e54e7b14eb99996590fb93b257cf881a9f184 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue-Endometrium|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.66e-05 | 170 | 83 | 5 | cdc19013da7c41d1ed8400a6a643e4c684ff9912 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.66e-05 | 170 | 83 | 5 | 0bde0a40440c7fdf7ba89cac8831d4014e7a4807 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.66e-05 | 170 | 83 | 5 | 516b38c4ecf6b0b04c5d4f80c510dcc00b328c6f | |
| ToppCell | Control-B_naive-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.71e-05 | 171 | 83 | 5 | d18855b24aadea38fd1e4592f945cf15b85e05f1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.81e-05 | 173 | 83 | 5 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.31e-05 | 182 | 83 | 5 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-05 | 183 | 83 | 5 | ec3c05b9ce1e0fbb720e0dea41f1e28fd3fd878f | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.43e-05 | 184 | 83 | 5 | 15ea746c77785120f69f9ab370fb7eb9b70692f8 | |
| ToppCell | droplet-Spleen-nan-24m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-05 | 184 | 83 | 5 | b998803180322a5ea2b567928dea531c26816c3c | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.43e-05 | 184 | 83 | 5 | a2191dd5546efd357b23e625beb3c5820476f243 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.43e-05 | 184 | 83 | 5 | 8fa30789c9d583188667cf375d2218e392dd40bc | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-alveolar_macrophage|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.43e-05 | 184 | 83 | 5 | bd5e8fc453a6393b8778734a2c3c2f1281769bcd | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-05 | 184 | 83 | 5 | 3261d767d5e3d9e9fbac22ad73ca14e44beed89c | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.49e-05 | 185 | 83 | 5 | b5277190866d9eb5b85eceaa5ba116ea6e6f286b | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.49e-05 | 185 | 83 | 5 | 4bee178ede12f56ba5f5bec44a03dc2a62c50137 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-05 | 186 | 83 | 5 | f1aa0c58336d23bcbe52a59e7af954d20085bdb6 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-05 | 186 | 83 | 5 | 8f77e552e613b6e124443c7f6ef5c1316a5ff8db | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-05 | 187 | 83 | 5 | f0c6e53035b00772377c4d5f761b4d11026b911a | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-05 | 187 | 83 | 5 | f20e7a1751694390f535ffb27b97e887220f8695 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.62e-05 | 187 | 83 | 5 | 97e520705491c8f52a32025311a9fa7b9176979a | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.69e-05 | 188 | 83 | 5 | 8f6b45ad82bde65e044d17f0edbc3db90d457915 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 189 | 83 | 5 | 287e59104687fe1665232c52993889f0f2c97f17 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.76e-05 | 189 | 83 | 5 | b2542b6fcf7bc10d29158d42b03182a939ff135a | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.76e-05 | 189 | 83 | 5 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-05 | 192 | 83 | 5 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.05e-05 | 193 | 83 | 5 | bd0027fa97de41ae22ff64a61c8e217496f122ca | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 3.45e-05 | 198 | 83 | 5 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.62e-05 | 200 | 83 | 5 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.62e-05 | 200 | 83 | 5 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | RV-14._Fibroblast_III|RV / Chamber and Cluster_Paper | 1.36e-04 | 140 | 83 | 4 | b4fee8eb6bf855b364b00bda3f78e49d851bbca0 | |
| ToppCell | Mild/Remission-B_naive-1|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.48e-04 | 143 | 83 | 4 | bd3f5fbd4e9e4dc414682db5607494f3ce988deb | |
| ToppCell | ASK454-Epithelial-Secretory|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.52e-04 | 144 | 83 | 4 | 8e693b50bd6c69ce68f44ca6e51f6d0c7f80d82c | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.60e-04 | 146 | 83 | 4 | a317f14a1aab11ffcce65baeb1c475c04324315f | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.73e-04 | 149 | 83 | 4 | 768877bade04ca0321593b8470b5011ad8270431 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Tox|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.33e-04 | 64 | 83 | 3 | bf923a66b17e717b8d3817b9d0e201b82a7e4a88 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Kctd12|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.33e-04 | 64 | 83 | 3 | 2edc3ae3e334bb04a411778e3b102b3a84a97824 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Kctd12-Inhibitory_Gad1Gad2Slc17a8_Htr3a.Ktcd12_(Interneuron,__GABA/Glutamate_co-releasing?_(candidate_CGE-derived_9))-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.33e-04 | 64 | 83 | 3 | b8aac6e83c2e5b09b55ea22ddb29940099f186e1 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Tox-Inhibitory_Gad1Gad2_Cplx3.Tox_(Interneuron,_lacunosum_oriens1?)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.33e-04 | 64 | 83 | 3 | a3e852600c53b11175eb579e92962fa711f5678b | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Kctd12-Inhibitory_Gad1Gad2Slc17a8_Htr3a.Ktcd12_(Interneuron,__GABA/Glutamate_co-releasing?_(candidate_CGE-derived_9))|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.33e-04 | 64 | 83 | 3 | 3e3eed30abcecd3fc8d30489dca05222ac353180 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Tox-Inhibitory_Gad1Gad2_Cplx3.Tox_(Interneuron,_lacunosum_oriens1?)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.33e-04 | 64 | 83 | 3 | f8f43ad9354c786b418bac54614f96f50e8bea68 | |
| ToppCell | P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.33e-04 | 161 | 83 | 4 | b19f82dd98a3064581793711bb70373f18abecd9 | |
| ToppCell | Control-MAIT|World / Disease group and Cell class | 2.44e-04 | 163 | 83 | 4 | 0ca4b835936b4f82217cbe57210c1dd90986c1d0 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.44e-04 | 163 | 83 | 4 | f1ec2625b52664308968b01d8e0275e1e0751480 | |
| ToppCell | facs-Skin-nan-24m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-04 | 164 | 83 | 4 | 7a65c7a6dbe5fb9067f83efafbb7ec8206d79325 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_1|COVID-19_Mild / Disease condition and Cell class | 2.56e-04 | 165 | 83 | 4 | ef709c5d3231c65d351316e1e31b9c9eba721628 | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.62e-04 | 166 | 83 | 4 | f62db9d9b6c9dd8f2afcaea0fc5f8c69f50205b2 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.62e-04 | 166 | 83 | 4 | a7ac5a414e3e2ff01f1c452c0a85048b17cba0b6 | |
| ToppCell | 343B-Lymphocytic-ILC|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.62e-04 | 166 | 83 | 4 | a54377c703efff42d2cc1a8fdb610facc58053dd | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.68e-04 | 167 | 83 | 4 | 1e144c03409df94ccd39760842590e8ea7487e29 | |
| ToppCell | droplet-Heart-nan-18m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-04 | 168 | 83 | 4 | 2201ae834b53cbdc085f8f02607fa5b5bd911268 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.74e-04 | 168 | 83 | 4 | 217770a94ace446cdfc7687b459dece707576e76 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.74e-04 | 168 | 83 | 4 | 7abaddbcc55e44653d54aa15464266aa6bd5c9d2 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_ETV4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.80e-04 | 169 | 83 | 4 | 716e9d4c5fb99c56b76afaa5ed90bfa859fde802 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.87e-04 | 170 | 83 | 4 | 417b77c12a7982b1ce4b4bc57f30335d261220f5 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-monocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-04 | 171 | 83 | 4 | 992df143d76f9e7fb1997a8996f61e941f0f9d4f | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper | 2.93e-04 | 171 | 83 | 4 | e99ecae66530d1ae09330cee408c8f3950b87e67 | |
| ToppCell | Control-MAIT|Control / Disease group and Cell class | 3.00e-04 | 172 | 83 | 4 | 552bc62e8e8bb0ac1cd0452f4410a3af087787eb | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 3.00e-04 | 172 | 83 | 4 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-04 | 173 | 83 | 4 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-04 | 173 | 83 | 4 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-04 | 173 | 83 | 4 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.06e-04 | 173 | 83 | 4 | 95c723b09254ae7131fe5ba0841472502e83269b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.13e-04 | 174 | 83 | 4 | e4d65fe121a32ac4cdd6312e7b8f867f0852e991 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.13e-04 | 174 | 83 | 4 | 99eb5e1aee136c7039e23b68a43a0fa3d775859f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.13e-04 | 174 | 83 | 4 | 7d4b860e05b5931f6f9d757a68f75ff35597a47a | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.20e-04 | 175 | 83 | 4 | d3890bd0c570bb81434fdd1c5229891cefe2e462 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.20e-04 | 175 | 83 | 4 | a3f8c54c77bce9b035a4835945ab341909be4946 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.27e-04 | 176 | 83 | 4 | cb8fd56a4f935cdda19d7ab43382cdda7c307667 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.34e-04 | 177 | 83 | 4 | 4c069f0d044a96118090b85ca592a21d6b5d9399 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.41e-04 | 178 | 83 | 4 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.48e-04 | 179 | 83 | 4 | 111b1084f73306bdeffaaf240e7dbb4f5bf33de1 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.56e-04 | 180 | 83 | 4 | b514c55e52b46e8a1a2f09ed2c59a7683367a505 | |
| ToppCell | facs-Bladder-nan-24m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-04 | 180 | 83 | 4 | 12537d8a569faa69f474284d2c201475722b8ca1 | |
| ToppCell | RA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 3.63e-04 | 181 | 83 | 4 | 2b6ddeb53a79a658e2ba78527ff48c155b20daa6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.63e-04 | 181 | 83 | 4 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.63e-04 | 181 | 83 | 4 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.71e-04 | 182 | 83 | 4 | 8a8b08ac4bb3cba3541dbe234e088703842285b9 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.71e-04 | 182 | 83 | 4 | a05e5978ef5f7fac7eeb2ba1c0103ea90d5e9136 | |
| ToppCell | COVID-19_Mild-CD4+_T_activated|COVID-19_Mild / Disease condition and Cell class | 3.71e-04 | 182 | 83 | 4 | 877b6e611626628e709568747512f2827ebb2795 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.71e-04 | 182 | 83 | 4 | 8d8f28bd43108b2fb3a6c2a3d77a897853d440a4 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.71e-04 | 182 | 83 | 4 | 831b5ce46b41efe01c4db6016c2f43148611373d | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.71e-04 | 182 | 83 | 4 | c7f2d24697affa530b748ab32b1d40bdc1bdc20a | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.71e-04 | 182 | 83 | 4 | d95635b74e8cd8bc00bfe40340806b59fb9bee43 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.71e-04 | 182 | 83 | 4 | e36766309c4d96a90d213ce37d3acef1029a3fdc | |
| ToppCell | ASK454-Immune-Macrophages|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.71e-04 | 75 | 83 | 3 | 572cea9d3f9afa218037550dacc3524534c673ce | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 3.79e-04 | 183 | 83 | 4 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 3.79e-04 | 183 | 83 | 4 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.87e-04 | 184 | 83 | 4 | 087666ba949b129c53d7ace40f9e543e3875a7de | |
| ToppCell | COVID-19_Convalescent-Myeloid-cDC|COVID-19_Convalescent / Disease group, lineage and cell class | 3.87e-04 | 184 | 83 | 4 | ad6e910eaebe841a68a5f2f329d43dafc5db158a | |
| ToppCell | PBMC-Convalescent-Myeloid-cDC-cDC|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.87e-04 | 184 | 83 | 4 | 9d678b24532b7763f2e73f7ccb496259977c5204 | |
| ToppCell | PBMC-Convalescent-Myeloid-cDC-cDC-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.87e-04 | 184 | 83 | 4 | 383374ad17bd322b8d703a22e475d34ca7b2e6b6 | |
| ToppCell | PBMC-Convalescent-Myeloid-cDC|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.87e-04 | 184 | 83 | 4 | 5535b85b3ad3d0c0392d5884fdc2939c7e1b1c3e | |
| Disease | eicosapentaenoic acid measurement | 8.17e-05 | 31 | 80 | 3 | EFO_0007760 | |
| Disease | orofacial cleft (is_implicated_in) | 1.51e-04 | 7 | 80 | 2 | DOID:0050567 (is_implicated_in) | |
| Disease | gastroesophageal reflux disease | 1.67e-04 | 101 | 80 | 4 | EFO_0003948 | |
| Disease | N-acetylcarnosine measurement | 2.01e-04 | 8 | 80 | 2 | EFO_0022101 | |
| Disease | obesity (implicated_via_orthology) | 3.02e-04 | 215 | 80 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | lung adenocarcinoma (is_implicated_in) | 3.23e-04 | 49 | 80 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 3.23e-04 | 49 | 80 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | 6.40e-04 | 1074 | 80 | 10 | C0006142 | |
| Disease | hepatoblastoma (is_marker_for) | 7.45e-04 | 15 | 80 | 2 | DOID:687 (is_marker_for) | |
| Disease | diabetic nephropathy | 7.52e-04 | 150 | 80 | 4 | EFO_0000401 | |
| Disease | intellectual disability (implicated_via_orthology) | 1.13e-03 | 75 | 80 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | Familial aplasia of the vermis | 1.34e-03 | 20 | 80 | 2 | cv:C0431399 | |
| Disease | Joubert syndrome 1 | 1.47e-03 | 21 | 80 | 2 | C4551568 | |
| Disease | Epilepsy, Benign Psychomotor, Childhood | 1.77e-03 | 23 | 80 | 2 | C0393672 | |
| Disease | Epilepsy, Lateral Temporal | 1.77e-03 | 23 | 80 | 2 | C0393682 | |
| Disease | Uncinate Epilepsy | 1.77e-03 | 23 | 80 | 2 | C0014558 | |
| Disease | Epilepsy, Temporal Lobe | 1.77e-03 | 23 | 80 | 2 | C0014556 | |
| Disease | Bipolar Disorder | 1.90e-03 | 477 | 80 | 6 | C0005586 | |
| Disease | peripheral arterial disease, traffic air pollution measurement | 1.94e-03 | 194 | 80 | 4 | EFO_0004265, EFO_0007908 | |
| Disease | response to TNF antagonist, joint damage measurement | 2.09e-03 | 25 | 80 | 2 | EFO_0004653, EFO_0005413 | |
| Disease | optic disc size measurement | 2.37e-03 | 205 | 80 | 4 | EFO_0004832 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 2.62e-03 | 28 | 80 | 2 | DOID:5409 (is_implicated_in) | |
| Disease | Disorder of eye | 2.67e-03 | 212 | 80 | 4 | C0015397 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MMDSSSFSNLDLSEE | 196 | P11473 | |
| EEDEDTMFTMVTDLS | 1646 | P13611 | |
| DMTTSVDFQEEATMD | 401 | Q9NP70 | |
| KMDASLTDTMEEFQE | 141 | O95267 | |
| DVLMETSGTDMLSDS | 531 | O15084 | |
| SANDMEDDSMDLIDS | 201 | Q6FI81 | |
| EISSDALTDDSMSMT | 301 | Q9Y2T1 | |
| ALTDDSMSMTDSSVD | 306 | Q9Y2T1 | |
| TEDESLSTMSCEMLT | 141 | P24386 | |
| MEDCDTEMEVDSSQL | 591 | Q96S59 | |
| MAEEMESSLEASFSS | 1 | Q9H082 | |
| ERSGMTTDDDTMSEM | 921 | Q6ZMN7 | |
| MASSSDSEDDSFMAV | 1 | Q6P3S6 | |
| ITREMVEMLFSDDSD | 81 | O60684 | |
| LESKEEESAMSSDRM | 241 | Q6WCQ1 | |
| CVTEVFMETSTMSTE | 201 | Q9Y5Y7 | |
| ADDATVMASESLSVM | 351 | Q9UBF1 | |
| TDEDAVLMDGMTESD | 511 | P51114 | |
| DCVVDEMDFSTMELD | 591 | Q6DN90 | |
| ILDAVSSDMFNEMES | 1686 | Q5CZC0 | |
| MEEESESESEQSMDS | 521 | Q13144 | |
| MSEMAELSELYEESS | 1 | Q9Y6B2 | |
| RKEFTDLMTEMTDLS | 1306 | Q9ULL4 | |
| DLMTEMTDLSSDLEG | 1311 | Q9ULL4 | |
| MSEKASSDLDMSSEV | 801 | Q8IVL0 | |
| TDDTNMADTFTEIMT | 506 | Q9ULH7 | |
| VMLDVTDTSMDTYLE | 351 | Q5W0B1 | |
| DKISELDSMMSESDN | 536 | Q5W0B1 | |
| SEDEDMFPIEMSSDE | 176 | Q14693 | |
| MDIDPSSSVLFEDME | 666 | Q93074 | |
| QFRTEMEDLMSSKDD | 1501 | P35579 | |
| MDIEDEENMSSSSTD | 1 | P78563 | |
| VLDCVVDEMDFSSME | 716 | Q9UPP2 | |
| VDEMDFSSMELDEAL | 721 | Q9UPP2 | |
| SSDTEMEDMIAEETL | 761 | Q8NDX5 | |
| DLEMMADDNIEDSTA | 126 | Q9C0H6 | |
| DEEMLETADGESMNT | 171 | P41236 | |
| SISMETLSDMFELDL | 801 | Q99613 | |
| DSISMETLSDMFELD | 801 | B5ME19 | |
| SMDEFIASDSDETSM | 1906 | P46100 | |
| ESLDSISEVDMDFTM | 106 | P24046 | |
| EMDDDTMFTTLGEED | 1221 | Q9P2D3 | |
| ECMSSELLEELMSSE | 361 | Q16254 | |
| IMMENSESETFDTLV | 661 | Q14185 | |
| VEAFTEEEMDMHISD | 1896 | Q9H799 | |
| DMEDEFEQPTMSFES | 421 | Q14241 | |
| DTMSESMNDQEEFIS | 636 | Q96MT8 | |
| FTVTMEDLMKTDADT | 91 | Q8TDQ1 | |
| TTSTMRGDMVTEDAD | 686 | Q9Y4J8 | |
| MSEDESEMITTVSEI | 406 | Q9C0D2 | |
| EMETSLDSSEMAKDL | 536 | Q96T23 | |
| ESLDSISEVDMDFTM | 86 | P28476 | |
| EEEMMEGETNFSSEI | 41 | Q8N108 | |
| FEEEMDTSPMVSSLL | 71 | Q9H2X9 | |
| SDSDLMGKTMTEDDD | 391 | Q8NEY1 | |
| EEICDMDSSEAMSLE | 1836 | Q5UIP0 | |
| MEVMDVFSTDDLTGF | 196 | Q6IN84 | |
| EETDNMDFSSMTLTQ | 961 | O00291 | |
| SLISECMDSEAETVM | 1891 | Q8IVL1 | |
| FEQEMAMVASSSSLE | 886 | P0CG39 | |
| DDDIETNSSTFMKEM | 726 | O15457 | |
| TSYVIESDEDLEMEM | 461 | Q14191 | |
| ISELSSEVMGTMDAF | 266 | P57073 | |
| MTLSTEESIEMFGDI | 1 | Q7Z745 | |
| TMTDLDEQEDESMET | 376 | Q8TAQ2 | |
| QLLSDDETKDDMSMS | 1141 | Q66K14 | |
| GMDLSEELMFSSEVE | 381 | Q96Q45 | |
| SALITDEDEDMLSYM | 176 | A0A494C1R9 | |
| SALITDEDEDMLSYM | 176 | P0CV99 | |
| ESDASMDSDASMDSE | 2526 | Q99973 | |
| DEEMLETADGESMNT | 171 | Q6NXS1 | |
| EESTNMVEFMSAEDD | 441 | Q5T4T6 | |
| TDSEETVFTSEMCLM | 1476 | Q9BX26 | |
| MSVSRTMEDSCELDL | 1 | Q9HBL0 | |
| MLTFMASDSEEEVCD | 1 | P49810 | |
| MHTDLDTDMDMDTET | 1 | Q8IYK8 | |
| EMDSESHISETSDRM | 71 | Q63HK5 | |
| MTMLQESFSFDDLSV | 1 | P51523 | |
| SDDITDMISESKMDN | 496 | Q86YA3 | |
| SDELDIDETASDMSM | 1566 | P31629 | |
| DFEMVSESMVLETAE | 2766 | Q5T4S7 | |
| EASMDMDLLESSNIS | 606 | Q69YN4 | |
| IYESDDINSIMSEME | 691 | A6NCI4 | |
| EDSMDAMEILTPTSS | 2366 | Q15911 | |
| TFPFEEIDFSMEESM | 431 | P35573 | |
| TDEEDMGMTYAELSV | 586 | Q6IA69 | |
| EDSKMDSFLDMQLTE | 126 | Q86UW6 |